Independent, evidence-rated longevity research. No supplement sponsorships. No pharma ads. Structured judgment from a finance analyst and a doctor.
| ConsumerLab | Examine.com | closelook.health | |
|---|---|---|---|
| Purity testing | ✓ | — | — |
| Study aggregation | — | ✓ | ✓ |
| Evidence-level scoring | — | Partial | ✓ Ladder |
| Independent A/B/C ratings | — | — | ✓ |
| Medical editor review | Lab team | Editorial | ✓ Doctor |
| Zero supplement/pharma ads | — | — | ✓ |
| Written for finance pros | — | — | ✓ |
Randomized controlled trials with clinically meaningful endpoints. Gold standard.
Human studies with biomarker or surrogate endpoints. Promising, not definitive.
Robust animal data with understood molecular mechanisms. Plausible translation.
Promising model organism results, limited mechanistic understanding.
Cell studies, computational models, theoretical mechanisms only.
Biological processes that drive aging. Deep dives into the science, translated for non-specialists.
Single-compound research reports. Evidence chain from animal models to human trials.
Chronic diseases and aging conditions. Latest research, evidence levels, off-label options.
"closelook.health never accepts sponsorships from supplement or pharmaceutical companies. Our sponsors — if we choose to have any — are testing services and health data platforms. Never the compounds we cover."
€15–25/mo for scorecards, protocol stacks, quarterly Evidence Ladder updates, Ask-the-Doctor Q&A
Oura, InsideTracker, glucose monitors. Testing & monitoring only. Never supplement brands.
Testing services and health data platforms only. Published policy: no supplements, no pharma.
ABR-style scoring for interventions. Systematic rating framework. Needs 20+ posts foundation.
Managing Director, Closelook Venture GmbH. Quantitative frameworks applied to longevity science.
Specialist in anti-aging and preventive medicine. Reviews every scorecard and protocol stack.